medigraphic.com
ISSN 2992-8036 (Electronic)
ISSN 2306-4102 (Print)
Órgano Oficial del Colegio Mexicano de Ortopedia y Traumatología

2023, Number 6

<< Back Next >>

Acta Ortop Mex 2023; 37 (6)

Surgical margins as prognostic factor in pelvis chondrosarcoma. Cohort study in a sarcoma unit

Lizcano-Suárez A, Clara-Altamirano M, Velázquez-Rodríguez S, Martínez-Said H, Villavicencio-Valencia S, García-Ortega D

Language: Spanish
References: 25
Page: 331-337
PDF size: 169.13 Kb.


ABSTRACT

Introduction: chondrosarcoma is the second most common primary malignant tumor, constitutes approximately one quarter of all primary bone sarcomas. Surgical margins in pelvic chondrosarcoma have a direct impact as a prognostic factor, both on overall survival and on recurrence-free survival of this disease. Objectives: to analyze the impact of surgical margins as a prognostic factor in pelvic chondrosarcoma. Material and methods: a retrospective database cohort with prospective follow-up of sarcomas in patients diagnosed with primary pelvic chondrosarcoma who underwent surgical treatment. Clinical-demographic variables were obtained, a descriptive analysis of each variable was performed, and these were contrasted with the outcome variables. Results: seventeen patients were included, of which nine were female. The median age was 41 years, ranging from 23 to 65 years. The average tumor size was 20.9 cm (range 5 to 46 cm). The average surgical margin was 5.3 mm, ranging from 1 to 30 mm, with 58% positive margins. The average overall survival was 64 months (range 7 to 108 months). The distribution of pelvic involvement was as follows: zone I in nine patients (52.9%), zone II in two (11.8%), a combination of zones I-III in two (11.8%), I+II in one (5.9%), II+III in one (5.9%), I-III plus sacrum in one (5.9%) and I plus sacrum in one (5.9%). Tumor grades were classified as low in seven patients (41.2%), intermediate in sven (41.2%), high in two (11.8%), and dedifferentiated in one (5.9%). Regarding the type of resection, 12 patients (70.6%) underwent internal hemipelvectomy and five (29.4%) external hemipelvectomy. Recurrence was recorded in five cases (29.4%), metastasis in three (17.6%), and mortality in four (23.5%). Conclusions: this series represents the largest cohort reported in Latin America of primary pelvic chondrosarcomas. A more favorable prognosis was observed in patients with surgical margins greater than 1 mm. The presence of chondrosarcoma in multiple pelvic zones was associated with a worse oncological prognosis. Additionally, a higher incidence of positive surgical margins and local recurrence rates were identified in pelvic chondrosarcomas compared to those located in the extremities.


REFERENCES

  1. Gazendam A, Popovic S, Parasu N, Ghert M. Chondrosarcoma: a clinical review. J Clin Med. 2023; 12(7): 2506. Available in: https://pubmed.ncbi.nlm.nih.gov/37048590/

  2. Giuffrida AY, Burgueno JE, Koniaris LG, Gutierrez JC, Duncan R, Scully SP. Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database. J Bone Joint Surg Am. 2009; 91(5): 1063-72. Available in: https://pubmed.ncbi.nlm.nih.gov/19411454/

  3. Fromm J, Klein A, Baur-Melnyk A, Knosel T, Lindner L, Birkenmaier C, et al. Survival and prognostic factors in conventional G1 chondrosarcoma. World J Surg Oncol. 2019; 17(1): 1-7. Available in: https://wjso.biomedcentral.com/articles/10.1186/s12957-019-1695-4

  4. Normal A, Sissons HA. Radiographic hallmarks of peripheral chondrosarcoma. Radiology. 1984; 151(3): 589-96. Available in: https://pubmed.ncbi.nlm.nih.gov/6718712/

  5. Douis H, Parry M, Vaiyapuri S, Davies AM. What are the differentiating clinical and MRI-features of enchondromas from low-grade chondrosarcomas? Eur Radiol. 2018; 28(1): 398-409. Available in: https://pubmed.ncbi.nlm.nih.gov/28695356/

  6. Nazeri E, Gouran Savadkoohi M, Majidzadeh-A K, Esmaeili R. Chondrosarcoma: An overview of clinical behavior, molecular mechanisms mediated drug resistance and potential therapeutic targets. Crit Rev Oncol Hematol. 2018; 131: 102-9.

  7. Evans HL, Ayala AG, Romsdahl MM. Prognostic factors in chondrosarcoma of bone. A clinicopathologic analysis with emphasis on histologic grading. Cancer. 1977; 40(2): 818-31.

  8. Laitinen MK, Stevenson JD, Parry MC, Sumathi V, Grimer RJ, Jeys LM. The role of grade in local recurrence and the disease-specific survival in chondrosarcomas. Bone Joint J. 2018; 100-B(5): 662-6. Available in: https://pubmed.ncbi.nlm.nih.gov/29701096/

  9. Choi JH, Ro JY. The 2020 WHO classification of tumors of soft tissue: selected changes and new entities. Adv Anat Pathol. 2021; 28(1): 44-58. Available in: https://pubmed.ncbi.nlm.nih.gov/32960834/

  10. Unni KK. Cartilaginous lesions of bone. J Orthop Sci. 2001; 6(5): 457-72. Available in: https://pubmed.ncbi.nlm.nih.gov/11845358/

  11. Biermann JS, Chow W, Reed DR, Lucas D, Adkins DR, Agulnik M, et al. NCCN Guidelines insights: bone cancer, version 2.2017. J Natl Compr Canc Netw. 2017; 15(2): 155-67. Available in: https://pubmed.ncbi.nlm.nih.gov/28188186/

  12. Chow WA. Chondrosarcoma: biology, genetics, and epigenetics. F1000Res. 2018; 7. doi: 10.12688/f1000research.15953.1.

  13. Tsuda Y, Evans S, Stevenson JD, Parry M, Fujiwara T, Laitinen M, et al. Is the width of a surgical margin associated with the outcome of disease in patients with peripheral chondrosarcoma of the pelvis? A multicenter study. Clin Orthop Relat Res. 2019; 477(11): 2432-40. doi: 10.1097/CORR.0000000000000926

  14. Donati D, El Ghoneimy A, Bertoni F, Di Bella C, Mercuri M. Surgical treatment and outcome of conventional pelvic chondrosarcoma. J Bone Joint Surg Br. 2005; 87(11): 1527-30. Available in: https://pubmed.ncbi.nlm.nih.gov/16260673/

  15. Stevenson JD, Laitinen MK, Parry MC, Sumathi V, Grimer RJ, Jeys LM. The role of surgical margins in chondrosarcoma. Eur J Surg Oncol. 2018; 44(9): 1412-8. Available in: https://pubmed.ncbi.nlm.nih.gov/29929901/

  16. Fiorenza F, Abudu A, Grimer RJ, Carter SR, Tillman RM, Ayoub K, et al. Risk factors for survival and local control in chondrosarcoma of bone. J Bone Joint Surg Br. 2002; 84-B(1): 93-9.

  17. Gelderblom H, Hogendoorn PCW, Dijkstra SD, van Rijswijk CS, Krol AD, Taminiau AHM, et al. The clinical approach towards chondrosarcoma. Oncologist. 2008; 13(3): 320-9. Available in: https://pubmed.ncbi.nlm.nih.gov/18378543/

  18. Andreou D, Ruppin S, Fehlberg S, Pink D, Werner M, Tunn PU. Survival and prognostic factors in chondrosarcoma: results in 115 patients with long-term follow-up. Acta Orthop. 2011; 82(6): 749-55. Available in: https://pubmed.ncbi.nlm.nih.gov/22066552/

  19. Nota SPFT, Braun Y, Schwab JH, Van Dijk CN, Bramer JAM. The identification of prognostic factors and survival statistics of conventional central chondrosarcoma. Sarcoma. 2015; 2015: 623746.2. Available in: https://pubmed.ncbi.nlm.nih.gov/26633939/

  20. Crimì A, Binitie OT, Crimì F, Letson GD, Joyce DM. Outcomes and complications of pelvic chondrosarcomas treated using navigation guidance and multidisciplinary approach: is the tumor volume a prognostic factor? J Clin Med. 2022; 11(23): 7111. doi: 10.3390/jcm11237111.

  21. Afonso PD, Isaac A, Villagrán JM. Chondroid tumors as incidental findings and differential diagnosis between enchondromas and low-grade chondrosarcomas. Semin Musculoskelet Radiol. 2019; 23(1): 3-18. Available in: https://pubmed.ncbi.nlm.nih.gov/30699449/

  22. Nakagawa M, Sekimizu M, Endo M, Kobayashi E, Iwata S, Fukushima S, et al. Prognostic impact of IDH mutations in chondrosarcoma. J Orthop Sci. 2022; 27(6): 1315-22.

  23. Coleman WB, Tsongalis GJ. Molecular mechanisms of human carcinogenesis. EXS. 2006; (96): 321-49. Available in: https://pubmed.ncbi.nlm.nih.gov/16383025/

  24. Miwa S, Yamamoto N, Hayashi K, Takeuchi A, Igarashi K, Tsuchiya H. Therapeutic targets and emerging treatments in advanced chondrosarcoma. Int J Mol Sci. 2022; 23(3): 1096. doi: 10.3390/ijms23031096.

  25. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004; 240(2): 205-13. Available in: https://pubmed.ncbi.nlm.nih.gov/15273542/



EVIDENCE LEVEL

II




2020     |     www.medigraphic.com